Securities Class Actions – Page 2 – ClaimsFiler

Case Type: Securities Class Actions

On January 24, 2025, Novo Nordisk A/S was sued for violations of the federal securities laws in the  United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired Novo securities between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

On January 24, 2025, ESSA Pharma Inc. was sued for violations of the federal securities laws in the  United States District Court for the District of Wisconsin on behalf of investors who purchased or otherwise acquired ESSA securities between December 12, 2023 and October 31, 2024, both dates inclusive (the “Class Period”).

On January 22, 2025, Crocs, Inc. was sued for violations of the federal securities laws in the  United States District Court for the District of Delaware on behalf of investors who purchased or otherwise acquired Crocs common stock between November 3, 2022, and October, 28 2024, inclusive (the “Class Period”).

On January 22, 2025, Cardlytics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of Georgia on behalf of investors who purchased the Company’s shares between March 14, 2024 and August 7, 2024, inclusive (the “Class Period”).

On January 17, 2025, Block, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Northern District of California on behalf of all purchasers of Block Class A common stock between February 26, 2020 and April 30, 2024, inclusive (“Class Period”).

On January 17, 2025, Innovative Industrial Properties, Inc. was sued for violations of the federal securities laws in the  United States District Court for the District of Maryland on behalf of investors who purchased or otherwise acquired IIPR securities between February 27, 2024 and December 19, 2024, both dates inclusive (the “Class Period”).

On January 17, 2025, FTAI Aviation Ltd. was sued for violations of the federal securities laws in the  United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise
acquired FTAI securities between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

On January 13, 2025, Pacira Biosciences, Inc. was sued for violations of the federal securities laws in the  United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired Pacira securities between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

On January 9, 2025, Micron Technology, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Southern District of Florida on behalf of investors who purchased or otherwise acquired Micron common stock between September 28, 2023 and December 18, 2024, both dates inclusive (the “Class Period”).

On January 7, 2025, Regeneron Pharmaceuticals, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise
acquired Regeneron securities between November 2, 2023 and October 30, 2024, inclusive (the “Class Period”).

On January 7, 2025, BioAge Labs, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Northern District of California on behalf of investors who purchased stock pursuant and/or traceable to BioAge’s registration statement for the initial public offering held on or about September 26, 2024.

On January 3, 2025, Revance Therapeutics, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Middle District of Tennessee on behalf of investors who purchased or otherwise acquired Revance securities between February 29, 2024 and December 6, 2024, both dates inclusive (the “Class Period”).

On December 27, 2024, Nextracker Inc. was sued for violations of the federal securities laws in the  United States District Court for the Northern District of California on behalf of purchasers of Nextracker common stock between February 1, 2024 and August 1, 2024, both dates inclusive (the “Class Period”).

On December 26, 2024, Transocean Ltd. was sued for violations of the federal securities laws in the  United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Transocean securities between October 31, 2023 and September 2, 2024, inclusive (the “Class Period”).

On December 24, 2024, Caribou Biosciences Inc. was sued for violations of the federal securities laws in the  United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Caribou securities between July 14, 2023 and July 16, 2024, both dates inclusive (the “Class Period”).

On December 23, 2024, Capri Holdings Limited was sued for violations of the federal securities laws in the  United States District Court for the District of Delaware on behalf of investors who purchased Capri stock or sold Capri puts between August 10, 2023 and October 24, 2024, both dates inclusive (the “Class Period”).

Astrazeneca PLC (NYSE: AZN)

On December 23, 2024, AstraZeneca PLC was sued for violations of the federal securities laws in the  United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired publicly traded AstraZeneca securities between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

On December 19, 2024, Joint Stock Company Kaspi.kz was sued for violations of the federal securities laws in the  United States District Court for the Central District of California on behalf of investors who purchasedor otherwise acquired publicly traded Kaspi.kz securities between January 19, 2024 and September 19, 2024 inclusive (the “Class Period”).

On December 17, 2024, Applied Therapeutics, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”).

On December 16, 2024, MGP Ingredients, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Southern District of New York on behalf of all purchasers of shares of the common stock of MGPI between May 4, 2023 through October 30, 2024, inclusive (the “Class Period”).

We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.

OK